Lilly vs Novo: bigger GLP-1 share gain in 2026: Tied within 1pp
64%YES chance
Yes
64%
No
36%
Now 64.3%
Resolution
Resolves to the manufacturer with the larger US GLP-1 prescription share gain across calendar 2026.
Source: https://www.iqvia.com/
Resolves by May 8, 2027.
Recent trades
- YES@tatumkim25.1 sh@ 64%16 SP
- YES@kaipatel110.5 sh@ 63%67 SP
- NO@elliotalvarez216.1 sh@ 58%80 SP
- NO@lanewalsh57.8 sh@ 68%18 SP
- YES@micahbennett40.5 sh@ 70%28 SP
- YES@blakeunderhill75.2 sh@ 54%39 SP
- YES@blakevargas68.7 sh@ 68%46 SP
- YES@sashapark30.8 sh@ 66%20 SP
- YES@tatumchen44.3 sh@ 64%28 SP
- YES@morgansantos62.5 sh@ 62%38 SP
- NO@sashapark156.3 sh@ 59%58 SP
- YES@briarlopez125.8 sh@ 66%80 SP
- YES@rileykim64.2 sh@ 61%38 SP
- NO@sashahayes129.9 sh@ 58%51 SP
- NO@tatumkim51.2 sh@ 64%18 SP
- YES@noelyoon60.3 sh@ 66%39 SP
- YES@finleyyoon69.6 sh@ 63%43 SP
- YES@caseyokafor131.7 sh@ 60%75 SP
Top holders
YES holders
No holders yet.
NO holders
No holders yet.
News
Refreshed every 6 hours
No news yet. Endcap's news crawler refreshes every 6 hours.
Discussion
- @wrenvargasWren Vargas27 days ago
interesting angle.